This document provides definitions and information about HIV/AIDS including:
- Definitions of HIV and AIDS
- Global and regional statistics on HIV/AIDS prevalence and deaths
- Modes of HIV transmission and risk factors
- Stages of HIV infection from acute to symptomatic disease
- Diagnosis and treatment of HIV/AIDS
- Nutritional complications and the role of dietitians in HIV/AIDS care
2. Definitions
HIV
Human Immunodeficiency Virus – a retrovirus
that targets the CD4 T helper immune cells
AIDS
Acquired Immunodeficiency Syndrome – the
final stage of HIV infection
The result of infection with HIV is a inability of
the body to defend itself against other invaders
leading to opportunistic infections
3. Introduction
Global Sub-Saharan Africa
People Living 40.3 million 25.8 million
With HIV/ AIDS *57% women
(2005)
New HIV Infections 4.9 million 3.2 million
(2005) (70%)
(14,000 people
infected everyday)
AIDS Related Deaths 3.1 million 2.4 million
(2005)
6. HIV transmission and risk
factors
Transmission of HIV
Fluids commonly associated with transmission of
HIV
○ Vaginal fluids
○ Semen
○ Blood and blood components
○ Breast milk
Behavioral risk factors
○ Sexual intercourse whether vaginal, anal or oral
Number of sexual partners
Intercourse with HIV infected
Unprotected sex( lack of use of barrier precautions)
Presence of STI (sexually transmitted infection)
Influence of alcohol and other substances that impairs
decision making
7. ○ Exposure to blood and blood
products
IV drug users
Improperly screened blood and
blood products
○ Congenital exposure
Exposure in pregnancy, labour and
breast feeding
8.
9.
10. Acute HIV infection
Due to initial infection and dissemination through out the
body and occurs 1-4 weeks after exposure
Common symptoms; Headache, fever, rash, sorethroat,
tiredness, muscle pain, enlarged lymph glands.
Usually <14 days but may be weeks or months.
Non specific and could easily pass for common viral infections
Others; Nausea, vomiting, diarrhea, weight loss and
acute psychological problems like irritability and
confusion
Amount of virus in blood and genital secretions is so
high. This is when most people are contagious. Occurs
in 70 % of individuals
11. Seroconversion
Body takes a few days to weeks to recognize a
foreign substance like a virus
Once substance is recognized, body produces
antibodies that attack it
For HIV, 6-12 weeks after the virus has entered the
body, antibodies are in sufficient quantities to be
detected by the usual tests
>95% people have positive tests by 3 months while
>99% of people have positive tests by 6 months
In most infections once antibodies and other
protective cells appear, organisms are eliminated
but not so with HIV
12. Asymptomatic HIV infection
For several years after one is HIV antibody test
positive, People with HIV infection feel good. No
clinical signs or symptoms
Person unaware of HIV infection unless tested
About 70-80% of people who are presently
infected with HIV are in this asymptomatic phase
HIV continues reproducing every day making
new viruses and destroying body’s defenses.
The body continues to produce new CD4s to
offset the loss
13. Virus in the blood remain low and constant
for many years
Eventually the body can’t quite keep up and
with time progressive depletion of CD4 occur
The duration of this stage depends on how
effective the body’s defenses were able to
control the initial infection and therefore the
amount of virus in blood(8-10 years)
Period is longer the earlier the age at time of
initial infection
14. Symptomatic HIV disease
Early symptomatic HIV disease
Declining CD4
Increasing virus in blood
Symptoms include Fever, unexplained weight loss, recurrent
diarrhea, headache, tiredness and skin problems
Late symptomatic HIV disease (AIDS)
Defense system is sufficiently compromised, the patient is
unable to control other infections leading to opportunistic
infections and cancers
Without treatment the patient on average dies within 1-3 years
Signs and symptoms typically parallels laboratory testing of CD4
counts
Individuals could have very low CD4 without symptoms
Risk of death from HIV infection with CD4 counts above 200 is
low
15. Progression to AIDS
Typical progressors: 8-10 years asymptomatic
HIV before developing AIDS
Fall in viremia following acute infection
Rapid progressors
Develop AIDS in 2-3 years following initial infection
High viral load during acute infection and levels do not
fall to those of typical progressors
Non progressors “long survivors”
Relatively stable immune function for more that 10
years. Stable CD4
Low viral burden
16. Factors influencing the time
course to progression to AIDS
Acute infection is symptomatic
Viral strain
Higher viral “set point”
Older age at sero conversion
Opportunistic infection or neoplasm
present
In Mother to child, signs of infection at
<3months
17. Clinical staging based on
Natural history
WHO staging into IV stages:
Stage I: Asymptomatic and has normal activity
Stage II: Symptomatic with weight loss, minor
skin problems, Herpes zooster
Stage III: unexplained chronic diarrhea,
unexplained prolonged fever, PTB; Usually bed
ridden < 50% of the day during last month
Stage IV: Opportunistic infection eg PCP,
Cryptococcal meningitis, Toxoplasma infection of
brain etc. Usually bed ridden > 50% of the day
during last month
18. Diagnosis of HIV/AIDS
Screening Tests licensed by the FDA
Test serum or plasma with high sensitivity to HIV
type 1 (HIV-1) antibodies
○ Enzyme-Linked Immunoabsorbent Assay (ELISA)
Confirmatory test
○ ELISA, Enzyme Immunoassay (EIA), Western
blot, modified Western blot, indirect
immunoflourescent antibody assay (FIA), and line
immunoassay (LIA)
Combination ELISA testing
○ Both antigen and antibodies
○ Earlier diagnosis
19. Treatment
Antiretroviral Therapies (ART)
Nucleoside reverse transcriptase inhibitors
Nonnucleoside reverse transcriptase inhibitors
Protease inhibitors
Fusion inhibitors
Highly active retroviral therapy (HAART)
Introduced in 1996
Combinations of ART medications (3 or more)
Aimed at interrupting viral life cycle and decreasing
viral load
Goal: < 50 copies/mL
Only prolong life and suppress symptoms, no cure
currently exists
20. HIV/AIDS Related
Clinical Complications
Neuropathy
Antiretroviral (ARV) therapies
Dementia
HIV infection, other infections, nutrient
deficiencies
Pulmonary disorders
HIV infection – low CD4 count
Cardiac Manifestations
Inflammation process, infections, ARV
medication
22. Role of
Dietitian in HIV/AIDS Care
Monitor caloric intake
Document nutritional adequacy
Recommend methods for increasing
intake
Education on proper diet and food safety
Monitor nutrition abnormalities from
treatment
Make recommendations to the rest of
the team in relation to nutrition
23. Nutrition Complications
Malnutrition
Malabsorption
Hypermetabolism
Diminished intake
○ Dysphagia – mouth lesions
○ Odynophagia – lesions to esophagus
○ Dygeusia
○ Diarrhea – intestinal dysfunction due to pathogen
○ Anorexia – neuropsychiatric, endocrinologic, or gastrointestinal
○ Early satiety
○ Nausea and vomiting – side effect of medication
○ Fever – opportunistic infections
○ Fatigue – lean body mass depletion
○ Apathy
○ Depression
24. Malnutrition leads to:
Malabsorption
Complications with treatment regimens
Decreased immune function
Organ dysfunction
Micronutrient deficiencies
Weight Loss – AIDS Wasting
A well-nourished HIV positive person with a
controlled viral load is more likely to be
able to withstand the effects of HIV
infection
26. Nutrition - Treatment Interaction
Efficacy of treatment dependent on
nutritional status maintenance and vice
versa
Low nutrition status drug efficacy:
○ Reduces drug absorption
○ Reduces activation and elimination of most drugs
Treatment nutrition status
○ Reduce muscular protein synthesis
○ Diarrhea
○ Nausea/Vomiting
○ Appetite Loss
27. Altered immune function
Leads to:
Hypermetabolism
Opportunistic infections
○ Candidiasis
○ Cytomegalovirus
○ Hepatitis C
○ Herpes Simplex
○ Mycobacterium Avium Complex (MAC)
○ P. Jeroveci (PCP)
○ Many more
29. Micronutrient Deficiencies
Caused by decreased absorption and
metabolism of nutrients and accelerated
turnover
Most common: Others documented:
○ Vitamin A Vitamin B6
○ Vitamin E Vitamin D
○ Vitamin B12 Folate
○ Selenium Carotenoids
○ Zinc Riboflavin
Copper
30. Weight Loss – AIDS
Wasting
AIDS Wasting: “involuntary loss of greater than
10% of baseline body weight, accompanied by
either chronic diarrhea (at least two loose
stools per day for greater than 30 days) or
chronic weakness and fever for 30 days or
longer In the absence of concurrent illness or
conditions” – CDC 1987
Recommended revisions:
○ Time frames for weight loss
○ Inclusion of body composition alterations
○ Guidelines for determining competing diagnoses
32. More important than weight loss is body
composition alterations
Decreased Body Cell Mass (BCM)– metabolically
active, cellular component of the body, which
makes up lean body mass
A loss of body cell mass of 54% is likely to result
in death in HIV-infected patients regardless of the
presence or absence of infectious complications.
33.
34. HAART in AIDS Wasting
Body composition changes despite weight
maintenance
Lean tissue wasting
Lipodystrophy syndrome –
abnormal fat distribution
○ Fat accumulates:
Abdomen
Dorsocervical – “buffalo lumps”
Breast areas
○ Subcutaneous fat loss:
Limbs
Face
Upper trunk
35. Nutrition Intervention
Goals:
Preserve body cell mass
Provide adequate amounts of all nutrients for
proper function
Minimize the symptoms of intestinal
malabsorption
Strategy Symptom Management
36. Nutrition Assessment
Should take place at diagnosis of
HIV
Patient-Generated Subjective
Global Assessment (PG-SGA)
Dietary Evaluation
Physical Assessment
Biochemical Assessment
Medical History
37. Measuring Body
Composition
Anthroprometrics
Tricep skinfold
Midarm Circumference
Bioelectrical impedance analysis (BIA)
○ Convenient, inexpensive, and non-invasive
method for evaluating body composition – body
cell mass
Dual energy x-ray absorptiometry (DEXA)
○ Measures subcutaneous and visceral fat stores
38. Biochemical Assessment
Selected biochemical measures for HIV
Immunologic
○ CD4 count
○ Viral Load
Hematologic
○ Hemoglobin Transferrin
○ Hematocrit Albumin
○ Mean Corpuscular Volume Prealbumin
○ Ferritin (Transthyretin)
39. Organ Function Cardiovascular
AST Total Cholesterol
ALT HDL
BUN LDL
Creatinine Triglycerides
Endocrine C-Reactive Protein
Glucose Electrolytes
Insulin Sodium
Glycoslated Potassium
Hemoglobin A1C
Testosterone
40. Energy & Protein Needs
Energy – based on need to maintain weight
Harris-Benedict Formula X 1.3 (wt maintenance )
and 1.5 (wt gain)
In the presence of fever increase 13% of the BEE
Protein – increased for infection
1.0 – 1.4 g/kg/day (maintenance) & 1.5 - 2 g/kg/day
( repletion)
In the presence of fever increase 10% of the total
prot
Needs vary depending on disease status,
presence of opportunistic infection or other
underlying medical conditions
41. Micronutrient Needs
Dietary Reference Intakes
Vitamin A – 700-900 μg/day
○ Immune function
Vitamin E – 15 mg/day
○ Immune function – antioxidant protection
Vitamin B12 – 2.4 mcg/day
○ Cognitive function
Selenium – 55 μg/day
○ Immune function – antioxidant protection
Zinc – 8-11mg/day
○ Immune function, slowed disease progression
42. Fluids & Electrolytes
Fluids : 30 -35 ml/kg (8 -12 glass)
Replacement of electrolytes (sodium,
potassium, and chloride) in the presence
of diarrhea and vomiting.
43. Symptom Management
Nausea and Vomiting
○ Replace fluids and electrolytes
○ Bland, odorless foods
○ Beverages between meals
○ Smaller, more frequent meals
○ Reduce fatty foods with early satiety
Diarrhea
○ Replace fluids and electrolytes – juice, sports drinks,
gelatin
○ Bland foods low in fiber and residue
○ Avoid fatty and gassy foods
○ Avoid lactose if problematic
44. Anorexia
○ Eat favorite foods often in relaxed settings
○ Add flavors and an array of colors
○ Keep snacks handy
○ Appetite stimulants
Oral lesions/chewing & swallowing problems
○ Moist, soft, and finely diced foods
○ Avoid spicy or acid-containing foods
○ Room temperature or cooler foods
○ Thickened liquids (swallowing)
○ Topical medicines
45. Nutrient Supplementation
Specific micronutrient supplementation has shown
various results, and general multivitamin
supplementation is recommended, while food
should be considered the main source of nutritional
needs.
Double-blind, placebo-controlled trail in Thailand – 21
nutrient multivitamin (N=481)
○ Significantly reduced risk of mortality in men and women
Observational study amount HIV-infected men in U.S.
taking daily multivitamin supplement (N=296)
○ 30% reduction in risk of progression to the diagnosis of
AIDS
○ Significantly reduced risk for low CD4+ counts
46. High energy, high-protein oral
supplement
Prospective intervention trial (N=17) Boston, MA
Take one high-energy, high protein, oral, liquid,
nutrition supplement daily for 6 weeks along
with dietary counseling
Upon entry, 16 of 17 averaged 14% below UBW
10 gained weight, 2 maintained
4 lost weight – possibly due to secondary
infection
Mean weight gain = 1.1 kg
47. Glutamine (GLN) -Antioxidant
Supplementation
Increase body cell mass in AIDS patients
with weight loss
○ Randomized, double-blind controlled trial (N=21)
○ Patients with >5% wt. Loss since disease diagnosis
○ Treatment group: 40.0 g/d GLN, 800 mg/d ascorbic
acid, 500 IU/d α-tocopherol, 27,000 IU/d β-carotene,
280 µg/d, and 2400 mg/d N-acetyl cysteine for 3 mo.
○ Treatment group gained 2.2 kg (3.2%) body weight and
gain 1.8 kg in body cell mass vs .3 kg body weight and
.4 kg body cell mass in control group
48. Conclusion
HIV/AIDS is a complicated disease and requires
critical assessment by a multidisciplinary team
Maintenance of body weight and composition is
crucial in delaying HIV/AIDS progression
Malnutrition leading to AIDS Wasting is of primary
concern in MNT
Symptom management is an effective way to
address factors leading to AIDS wasting
Nutrient supplementation may be necessary to
ensure weight and body composition maintenance
50. “Do What you Can
with what you Have
Where you Are !”
51. Assignment….
Nutrition & Bone health
Nutrition for oral & dental health
MNT for psychiatric disorder
Notas del editor
HIV (pink) enters the body and binds to dendritic cells (orange), which carry the virus to CD4+ T cells. Infected CD4+ T cells home to lymphoid tissue, where the infection is established. Virus replication accelerates, and massive viremia leads to the wide dissemination of virus throughout the body's lymphoid tissue. An HIV-specific immune response occurs and virus is trapped on the follicular dendritic cells of germinal centers in the lymphoid tissue. At this point, chronic, persistent infection is established despite an immunological response to the virus. Immune activation is an important driver of HIV replication and is mediated by the secretion of various cytokines and by aberrant cell signaling caused by interaction of the viral envelope with cellular receptors. Because there is usually only partial immunological control of virus replication, continual and accelerated production of virus ensues. This is associated with a rapid turnover of CD4+ T cells. Ultimately, lymphocyte depletion occurs, along with destruction of the architecture of lymphoid tissue
Contagious - capable of being transmitted by infection
The development of detectable antibodies in the blooddirected against an infectious agent. It normally takes some time for antibodies to develop after the initial exposure to the agent.